DE69841708D1 - Thimerosal-freie konservierungsmittel für impfstoffe - Google Patents

Thimerosal-freie konservierungsmittel für impfstoffe

Info

Publication number
DE69841708D1
DE69841708D1 DE69841708T DE69841708T DE69841708D1 DE 69841708 D1 DE69841708 D1 DE 69841708D1 DE 69841708 T DE69841708 T DE 69841708T DE 69841708 T DE69841708 T DE 69841708T DE 69841708 D1 DE69841708 D1 DE 69841708D1
Authority
DE
Germany
Prior art keywords
vaccines
preservatives
thimerosal
free preservative
preservative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841708T
Other languages
English (en)
Inventor
Assunta S Ng
John P Hennessey
Ralph J Mancinelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme LLC
Application granted granted Critical
Publication of DE69841708D1 publication Critical patent/DE69841708D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69841708T 1997-02-06 1998-02-03 Thimerosal-freie konservierungsmittel für impfstoffe Expired - Lifetime DE69841708D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3690097P 1997-02-06 1997-02-06
PCT/US1998/002283 WO1998034594A1 (en) 1997-02-06 1998-02-03 Thimerosal-free preservatives for vaccines

Publications (1)

Publication Number Publication Date
DE69841708D1 true DE69841708D1 (de) 2010-07-22

Family

ID=21891288

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841708T Expired - Lifetime DE69841708D1 (de) 1997-02-06 1998-02-03 Thimerosal-freie konservierungsmittel für impfstoffe

Country Status (6)

Country Link
EP (1) EP0971696B1 (de)
JP (1) JP2002515056A (de)
AT (1) ATE470434T1 (de)
CA (1) CA2278684C (de)
DE (1) DE69841708D1 (de)
WO (1) WO1998034594A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1150712T1 (sl) * 1999-02-05 2009-02-28 Merck & Co Inc Pripravek cepiva proti humanem papiloma virusu
US6245568B1 (en) * 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0202901D0 (en) * 2002-02-07 2002-03-27 Glaxosmithkline Biolog Sa Novel vaccine
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
FR2985663B1 (fr) * 2012-01-17 2015-03-27 Sanofi Pasteur Procede de formulation d'un vaccin contenant au moins deux antigenes susceptibles de s'adsorber sur de l'oxy hydroxyde d'aluminium
EP3442587B1 (de) * 2016-04-14 2021-08-18 Boehringer Ingelheim Animal Health USA Inc. Mehrfachdosierungszusammensetzungen mit einem antimikrobiellen polyamid oder octenidin als konservierungsstoff
JP7337145B2 (ja) * 2018-07-21 2023-09-01 バイオロジカル イー リミテッド 保存剤系を含むワクチン製剤
JOP20190242A1 (ar) * 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
WO1995011008A2 (en) * 1993-10-22 1995-04-27 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
ATE214603T1 (de) * 1995-06-30 2002-04-15 American Cyanamid Co Stabile makrolide und makrolide imptstoff- zusammensetzungen

Also Published As

Publication number Publication date
WO1998034594A1 (en) 1998-08-13
ATE470434T1 (de) 2010-06-15
EP0971696B1 (de) 2010-06-09
EP0971696A1 (de) 2000-01-19
CA2278684A1 (en) 1998-08-13
JP2002515056A (ja) 2002-05-21
EP0971696A4 (de) 2006-07-19
CA2278684C (en) 2007-04-10

Similar Documents

Publication Publication Date Title
EE200000065A (et) Bioloogiliselt aktiivseid makromolekule ja vett sisaldavad aerosoolpreparaadid ja nende aerosoolide saamise meetod
DE69841708D1 (de) Thimerosal-freie konservierungsmittel für impfstoffe
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
NO2005009I1 (no) Emselex-Darifenacin-IUPAC-nabn: (S)-2-(1-Ä2-(2,3-dihydrobenzofuran-5-yl)etylÜ3-pyrrolidinylÜ-2,2-difenylacetamid
DE59607158D1 (de) Ballenpresse, insbesondere selbstfahrende Grossballenpresse
FI960889A (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
FI20095804A (fi) Bentsotiofeeniyhdisteet, välituotteet, koostumukset ja menetelmät
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
EE04091B1 (et) Koostised ja meetodid silmasisese rõhu alandamiseks
FI962948A (fi) Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi
DE69608414T2 (de) Als insektizid aktive zusammensetzung
DE69711649D1 (de) P1, p4-dithio-p2,p3-monochloromethylen 5',5'''-diadenosin-p1,p4-tetraphosphat verwendet als anti-thrombose mittel
NO973575L (no) Ny konserveringsmiddelsammensetning
BR9608328A (pt) Derivados de benzil piperidina como agentes farmacêuticos
ITMI940506A0 (it) Derivati chinzolilamminici attivi come alfa-antagonisti
ATE210112T1 (de) Substituierte 4-biphenyl-4- hydroxybuttersäurederivate als matrix metallprotease inhibitoren
EE03857B1 (et) Ravimkoostised külmkuivatamiseks
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
ATE212221T1 (de) Verfahren zum herstellen von extrakt enthaltenden pharmazeutischen formulierungen
ATE205822T1 (de) Substituierte 4-arylbutyrsäurederivate als matrix metalloprotease inhibitoren
DK0944956T3 (da) Klasse forstærker
DK0888340T3 (da) 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin
FI933506A (fi) Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaatteja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
FR2736267B1 (fr) Conservateur pour composition vaccinale
NO960796L (no) Benzotiofenonforbindelser, mellomprodukter, sammensetninger og fremgangsmåter

Legal Events

Date Code Title Description
R081 Change of applicant/patentee

Ref document number: 971696

Country of ref document: EP

Owner name: SCHERING CORPORATION, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, US

Effective date: 20121213